163 related articles for article (PubMed ID: 9561072)
1. MR imaging of lymph nodes in patients with primary abdominal and pelvic malignancies using ultrasmall superparamagnetic iron oxide (Combidex).
Harisinghani MG; Saini S; Hahn PF; Weissleder R; Mueller PR
Acad Radiol; 1998 Apr; 5 Suppl 1():S167-9, discussion S183-4. PubMed ID: 9561072
[No Abstract] [Full Text] [Related]
2. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: radiographic-pathologic correlation.
Harisinghani MG; Saini S; Weissleder R; Hahn PF; Yantiss RK; Tempany C; Wood BJ; Mueller PR
AJR Am J Roentgenol; 1999 May; 172(5):1347-51. PubMed ID: 10227514
[TBL] [Abstract][Full Text] [Related]
3. Multicenter clinical trial of ultrasmall superparamagnetic iron oxide in the evaluation of mediastinal lymph nodes in patients with primary lung carcinoma.
Nguyen BC; Stanford W; Thompson BH; Rossi NP; Kernstine KH; Kern JA; Robinson RA; Amorosa JK; Mammone JF; Outwater EK
J Magn Reson Imaging; 1999 Sep; 10(3):468-73. PubMed ID: 10508310
[TBL] [Abstract][Full Text] [Related]
4. Pelvic lymph node topography for radiotherapy treatment planning from ferumoxtran-10 contrast-enhanced magnetic resonance imaging.
Dinniwell R; Chan P; Czarnota G; Haider MA; Jhaveri K; Jewett M; Fyles A; Jaffray D; Milosevic M
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):844-51. PubMed ID: 19095369
[TBL] [Abstract][Full Text] [Related]
5. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin MF; Roy C; Kinkel K; Thoumas D; Zaim S; Vanel D; Tuchmann C; Richard F; Jacqmin D; Delcourt A; Challier E; Lebret T; Cluzel P
Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography.
Bellin MF; Lebleu L; Meric JB
Abdom Imaging; 2003; 28(2):155-63. PubMed ID: 12592461
[TBL] [Abstract][Full Text] [Related]
7. Experimental investigation of the delivery pathway of ultrasmall superparamagnetic iron oxide to lymph nodes.
Frija G; Clément O; Le Guen O; Cuénod CA; Siauve N; Benderbous S
Acad Radiol; 1996 Aug; 3 Suppl 2():S299-300. PubMed ID: 8796586
[No Abstract] [Full Text] [Related]
8. Oral magnetic particles in MR imaging of the abdomen and pelvis.
Rinck PA; Smevik O; Nilsen G; Klepp O; Onsrud M; Oksendal A; Børseth A
Radiology; 1991 Mar; 178(3):775-9. PubMed ID: 1994417
[TBL] [Abstract][Full Text] [Related]
9. Use of ultrasmall superparamagnetic iron oxide in lymph node MR imaging in prostate cancer patients.
Barentsz JO; Fütterer JJ; Takahashi S
Eur J Radiol; 2007 Sep; 63(3):369-72. PubMed ID: 17689215
[TBL] [Abstract][Full Text] [Related]
10. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
11. USPIO-enhanced MRI for preoperative staging of gynecological pelvic tumors: preliminary results.
Keller TM; Michel SC; Fröhlich J; Fink D; Caduff R; Marincek B; Kubik-Huch RA
Eur Radiol; 2004 Jun; 14(6):937-44. PubMed ID: 14991323
[TBL] [Abstract][Full Text] [Related]
12. Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement.
Michel SC; Keller TM; Fröhlich JM; Fink D; Caduff R; Seifert B; Marincek B; Kubik-Huch RA
Radiology; 2002 Nov; 225(2):527-36. PubMed ID: 12409591
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance lymphography. Enhancement patterns using superparamagnetic nanoparticles.
Clément O; Guimaraes R; de Kerviler E; Frija G
Invest Radiol; 1994 Jun; 29 Suppl 2():S226-8. PubMed ID: 7928239
[No Abstract] [Full Text] [Related]
14. Phase III trial of oral magnetic particles in MRI of abdomen and pelvis.
MacVicar D; Jacobsen TF; Guy R; Husband JE
Clin Radiol; 1993 Mar; 47(3):183-8. PubMed ID: 8472481
[TBL] [Abstract][Full Text] [Related]
15. Trafficking of superparamagnetic iron oxide particles (Combidex) from brain to lymph nodes in the rat.
Muldoon LL; Varallyay P; Kraemer DF; Kiwic G; Pinkston K; Walker-Rosenfeld SL; Neuwelt EA
Neuropathol Appl Neurobiol; 2004 Feb; 30(1):70-9. PubMed ID: 14720178
[TBL] [Abstract][Full Text] [Related]
16. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
17. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
18. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of mediastinal lymph nodes: evaluation using a superparamagnetic contrast agent.
Pannu HK; Wang KP; Borman TL; Bluemke DA
J Magn Reson Imaging; 2000 Dec; 12(6):899-904. PubMed ID: 11105028
[TBL] [Abstract][Full Text] [Related]
20. Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes.
Mack MG; Balzer JO; Straub R; Eichler K; Vogl TJ
Radiology; 2002 Jan; 222(1):239-44. PubMed ID: 11756732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
